MEDICAL PROPERTIES TRUST INC (MPT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 600M 1.2B 1.8B Q2 '15: 358.6M Q3 '15: 392.4M Q4 '15: 441.9M Q1 '16: 480.9M Q2 '16: 507.4M Q3 '16: 519.4M Q4 '16: 541.1M Q1 '17: 562.5M Q2 '17: 603M Q3 '17: 653.1M Q4 '17: 704.7M Q1 '18: 753.4M Q2 '18: 788.5M Q3 '18: 808.9M Q4 '18: 784.5M Q1 '19: 759.9M Q2 '19: 750.6M Q3 '19: 778.3M Q4 '19: 854.2M Q1 '20: 967.9M Q2 '20: 1.1B Q3 '20: 1.2B Q4 '20: 1.2B Q1 '21: 1.3B Q2 '21: 1.4B Q3 '21: 1.5B Q4 '21: 1.5B Q1 '22: 1.6B Q2 '22: 1.6B Q3 '22: 1.6B Q4 '22: 1.5B Q1 '23: 1.5B Q2 '23: 1.4B Q3 '23: 1.4B Q4 '24: 995.5M Q1 '25: 948M Q2 '25: 921.8M Q3 '25: 933.5M Q4 '25: 972M Q1 '26: 1B Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '24 Q1 '26

Gross Profit TTM

0 500M 1B 1.5B Q2 '19: 594.7M Q3 '19: 619.9M Q4 '19: 686M Q1 '20: 830.4M Q2 '20: 990.6M Q3 '20: 1.1B Q4 '20: 1.2B Q1 '21: 1.3B Q2 '21: 1.4B Q3 '21: 1.4B Q4 '21: 1.4B Q1 '22: 1.4B Q2 '22: 1.4B Q3 '22: 1.4B Q4 '22: 1.4B Q1 '23: 1.2B Q2 '23: 1.2B Q3 '23: 1.2B Q4 '24: 921.4M Q1 '25: 833.3M Q2 '25: 791.7M Q3 '25: 833.5M Q4 '25: 881.7M Q1 '26: 894.1M Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '25 Q1 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

0 200M 400M 600M Q4 '10: 42.2M Q1 '11: 54M Q2 '11: 57.4M Q3 '11: 62.2M Q4 '11: 65.8M Q1 '12: 69.7M Q2 '12: 84.9M Q3 '12: 101.3M Q2 '13: 154.9M Q3 '13: 158.5M Q4 '13: 153.5M Q1 '14: 141.5M Q2 '14: 126.6M Q3 '14: 139.3M Q4 '14: 143M Q1 '15: 178M Q2 '15: 202M Q3 '15: 206M Q4 '15: 263.2M Q1 '16: 302.1M Q2 '16: 332.7M Q3 '16: 363.5M Q4 '16: 341.6M Q1 '17: 350.6M Q2 '17: 382.4M Q3 '17: 415.2M Q4 '17: 485.6M Q2 '11 Q2 '12 Q4 '13 Q4 '14 Q4 '15 Q4 '16 Q4 '17

Net Income TTM

-3B -2B -1B 0 1B 2B 3B Q2 '15: 101.8M Q3 '15: 96.3M Q4 '15: 139.6M Q1 '16: 161.6M Q2 '16: 192.9M Q3 '16: 240.2M Q4 '16: 225M Q1 '17: 235.1M Q2 '17: 254.8M Q3 '17: 260.9M Q4 '17: 289.8M Q1 '18: 312.4M Q2 '18: 350.6M Q3 '18: 1B Q4 '18: 1B Q1 '19: 1B Q2 '19: 969.8M Q3 '19: 323.5M Q4 '19: 374.7M Q1 '20: 379.9M Q2 '20: 409.9M Q3 '20: 451.2M Q4 '20: 431.4M Q1 '21: 514.2M Q2 '21: 519.3M Q3 '21: 559.4M Q4 '21: 656M Q1 '22: 1.1B Q2 '22: 1.2B Q3 '22: 1.2B Q4 '23: -556.5M Q1 '24: -1.5B Q2 '24: -1.7B Q3 '24: -2.7B Q4 '24: -2.4B Q1 '25: -1.7B Q2 '25: -1.4B Q3 '25: -707.2M Q4 '25: -277M Q1 '26: -125.9M Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '24 Q1 '26

Cost of Revenue TTM

-90M 0 90M 180M 270M Q2 '19: 155.9M Q3 '19: 158.5M Q4 '19: 168.2M Q1 '20: 137.4M Q2 '20: 76.6M Q3 '20: 70.4M Q4 '20: 30.1M Q1 '21: 707K Q2 '21: 55M Q3 '21: 58.4M Q4 '21: 101.4M Q1 '22: 153.4M Q2 '22: 198.5M Q3 '22: 188.3M Q4 '22: 167.4M Q1 '23: 255.5M Q2 '23: 171.2M Q3 '23: 198.2M Q4 '23: 110.1M Q1 '24: -31.1M Q2 '24: 1.9M Q3 '24: -19M Q4 '24: 74.2M Q1 '25: 114.7M Q2 '25: 130.1M Q3 '25: 100M Q4 '25: 90.3M Q1 '26: 106.2M Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Operating Cash Flow TTM

0 300M 600M 900M Q2 '16: 256.8M Q3 '16: 243.1M Q4 '16: 263.8M Q1 '17: 258.8M Q2 '17: 281.4M Q3 '17: 315.5M Q4 '17: 362.2M Q1 '18: 392.7M Q2 '18: 403.8M Q3 '18: 441.4M Q4 '18: 449.1M Q1 '19: 441.2M Q2 '19: 450.7M Q3 '19: 477.3M Q4 '19: 494.1M Q1 '20: 514.1M Q2 '20: 585.1M Q3 '20: 609M Q4 '20: 617.6M Q1 '21: 699.5M Q2 '21: 693.8M Q3 '21: 752.9M Q4 '21: 811.7M Q1 '22: 802.3M Q2 '22: 790.4M Q3 '22: 792.1M Q4 '22: 739M Q1 '23: 695.3M Q2 '23: 607.2M Q3 '23: 551.5M Q4 '23: 505.8M Q1 '24: 444.5M Q2 '24: 403.2M Q3 '24: 304.2M Q4 '24: 245.5M Q1 '25: 171.5M Q2 '25: 188M Q3 '25: 147.4M Q4 '25: 230.8M Q1 '26: 216.1M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 250M 500M 750M Q4 '14: 172.6M Q1 '15: 203.6M Q2 '15: 208.6M Q3 '15: 223.9M Q4 '15: 237M Q1 '16: 237.8M Q2 '16: 239M Q3 '16: 247.5M Q4 '16: 320M Q1 '17: 321.4M Q2 '17: 350.3M Q3 '17: 365M Q4 '17: 365M Q1 '18: 365.3M Q2 '18: 365.5M Q3 '18: 366.5M Q4 '18: 367.7M Q1 '19: 381.7M Q2 '19: 395.7M Q3 '19: 440.9M Q4 '19: 494.9M Q1 '20: 522.2M Q2 '20: 528.9M Q3 '20: 532.4M Q1 '21: 577.5M Q2 '21: 589.1M Q3 '21: 597.3M Q1 '22: 598.9M Q2 '22: 599M Q3 '22: 599.3M Q1 '23: 598.3M Q2 '23: 598.3M Q3 '23: 598.6M Q1 '24: 600.3M Q2 '24: 600.1M Q3 '24: 600.2M Q1 '25: 600.6M Q2 '25: 600.8M Q3 '25: 601.1M Q1 '26: 597.7M Q4 '15 Q1 '17 Q2 '18 Q3 '19 Q1 '21 Q3 '22 Q2 '24 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q2 '15: 0.52 Q3 '15: 0.46 Q4 '15: 0.62 Q1 '16: 0.69 Q2 '16: 0.80 Q3 '16: 0.98 Q4 '16: 0.87 Q1 '17: 0.84 Q2 '17: 0.83 Q3 '17: 0.76 Q4 '17: 0.82 Q1 '18: 0.86 Q2 '18: 0.95 Q3 '18: 2.74 Q4 '18: 2.76 Q1 '19: 2.71 Q2 '19: 2.61 Q3 '19: 0.81 Q4 '19: 0.86 Q1 '20: 0.81 Q2 '20: 0.82 Q3 '20: 0.87 Q4 '20: 0.81 Q1 '21: 0.94 Q2 '21: 0.92 Q3 '21: 0.96 Q4 '21: 1.11 Q1 '22: 1.88 Q2 '22: 2.01 Q3 '22: 2.09 Q4 '23: -0.94 Q1 '24: -2.45 Q2 '24: -2.92 Q3 '24: -4.45 Q4 '24: -4.03 Q1 '25: -2.77 Q2 '25: -2.39 Q3 '25: -1.18 Q4 '25: -0.46 Q1 '26: -0.21 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '24 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.